Hemokinin1(human)
Cat.No:CLP0811 Solarbio
CAS:491851-53-7
Molecular Formula:C54H84N14O14S1
Molecular Weight:1185.41
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
{{cart_num}}
My CartCAS:491851-53-7
Molecular Formula:C54H84N14O14S1
Molecular Weight:1185.41
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
Product Type | Peptides |
CAS | 491851-53-7 |
Sequence(1LC) | TGKASQFFGLM-NH2 |
Sequence(3LC) | Thr-Gly-Lys-Ala-Ser-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
Molecular Formula | C54H84N14O14S1 |
Molecular Weight | 1185.41 |
Purity | ≥95% |
Appearance | Lyophilized powder |
Solubility | H2O:≥50 mg/mL; *Ultrasonic solubilization; |
Salt Form | Trifluoroacetate salt |
Source | Synthetic |
Storage | Store at -20℃,2 years.(Avoid freeze/thaw cycles) |
Category/Label | Neuropeptides and Related Peptides |
Background | Hemokinin 1, human is a selective tachykinin neurokinin 1 (NK1) receptor full agonist. Hemokinin 1, human is a full agonist at NK2 and NK3 receptor. Hemokinin 1, human can produces an opioid-independent analgesia. |
Reference | [1] Fu C Y, Xia R L, Zhang T F, et al. Hemokinin-1 (4-11)-induced analgesia selectively up-regulates δ-opioid receptor expression in mice[J]. PloS one, 2014, 9(2): e90446; [2] Francesca Bellucci, et al. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br J Pharmacol. 2002 Jan;135(1):266-74. |
Unit | Bottle |
Specification | 1mg 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.